Provided by Tiger Trade Technology Pte. Ltd.

Roundhill Bitcoin Covered Call Strategy ETF

18.27
+0.10900.60%
Post-market: 18.23-0.0390-0.21%18:02 EDT
Volume:75.77K
Turnover:1.38M
Market Cap:144.51M
PE:- -
High:18.36
Open:18.21
Low:18.10
Close:18.16
52wk High:46.93
52wk Low:16.30
Shares:7.91M
Float Shares:7.91M
Volume Ratio:0.55
T/O Rate:0.96%
Dividend:13.04
Dividend Rate:71.39%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

The $4 Billion Signal: Bitcoin Isn't Trading The Buyback — It's Trading What Comes Next

Macro World​
·
Yesterday

World Liberty launches $4B USD1 on Canton Network

cryptonews
·
1 hour ago

Bitcoin Bull Score hits 80, but $83K close is key

cryptonews
·
1 hour ago

CoinDesk Bitcoin Price Index Gained 0.24% to $78934.96

Dow Jones
·
1 hour ago

LIVE Markets-Tech Finds Its Footing, but Wall Street's Rally Lacks Conviction

Reuters
·
1 hour ago

Top Cryptocurrencies Mixed; Bitcoin Holds Above $78,000 Level

MT Newswires Live
·
2 hours ago

Crypto market enters extreme greed for first time since 2024

cryptonews
·
2 hours ago

Dow Jones Top Markets Headlines at 3 PM ET: Canada Targets U.S. Metals, Fish, Foods, Motorcycles in Retaliatory Tariff Package | Bitcoin ...

Dow Jones
·
3 hours ago

Goldman Sachs backs crypto stocks amid Bitcoin breakout

cryptonews
·
3 hours ago

The 1996 Warning & Crypto Pivot

Blockhead
·
4 hours ago

Bitcoin Breaches $81,000 Mark as ETF Inflows Accelerate Crypto Rally

Deep News
·
4 hours ago

Bitcoin Rallies 0.2%

Dow Jones
·
5 hours ago

Dow Jones Top Markets Headlines at 1 PM ET: Bitcoin Rally Pauses After Jumping to Three-Month High | Canada ...

Dow Jones
·
5 hours ago

Author of "Rich Dad Poor Dad" Warns Holders of These "Fake Assets" Will Grow Poorer

Deep News
·
5 hours ago

Bitcoin's Blistering Rally Just Hit the Brakes. What Happens Next.

Dow Jones
·
Yesterday

Dow Jones Top Markets Headlines at 11 am ET: Bitcoin Rally Pauses After Jumping to 3-Month High | He ...

Dow Jones
·
Yesterday

Bitcoin Rally Pauses After Jumping to 3-Month High

Dow Jones
·
Yesterday

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Yesterday

Bitcoin Rally Faces Critical Test as Spot and Futures Demand Surge

Stock News
·
Yesterday

Bitcoin Faces $1.5B Liquidation Showdown at Key Price Zones

Stock News
·
Yesterday